Posted in | News | Solar Energy | Green Energy

New CIGSolar Cells from XsunX Achieve Conversion Efficiency

XsunX, a company that introduced hybrid, thin-film photovoltaic (TFPV) solar cell applications and production procedures, declared that it has further improved the conversion competence levels of its solar modules by utilizing its patented CIGSolar technology.

The conversion efficiency levels of the cells is said to have reached 15.1% in comparison to the 8-11% efficiency levels of the other cells currently available in the market. As per the research findings, the CIGS thin-film solar cells are capable of achieving 29% conversion efficiency but only a maximum of 20% has been achieved under laboratory test conditions till date.

XsunX has achieved the highest 15.1% conversion efficiency within a short period of time cost-efficiently when equated with the efforts of other companies that went on for a number of years with huge capital outlay. The quickly achieved invention success combined with the apparent value of the technology that can offer a clear and advantageous substitute for the existing silicon solar cells, has evoked the interest levels of the industry. The company performed the process of depositing the CIGS layers over a full sized 125 mm square substrate and conducted efficiency tests that are similar to that of National Renewable Energy Laboratory tests. It fine-tuned its equipment to the prescribed test standards of National Institute of Standards and Technology (NIST).

The company is currently holding discussions with various manufacturers on granting of license agreements as well as joint venture accords to distribute the know-how through the existing solar manufacturing companies. Such an arrangement with the existing, reputed solar module manufacturing companies will allow the companies to incorporate the CIGSolar technology in their modules and will save XsunX from making huge investments to start its own manufacturing facilities.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.